Bionano Genomics, Inc. Warrant
BNGOW
BNGOW was delisted on the 17th of August, 2023.
4 hedge funds and large institutions have $170K invested in Bionano Genomics, Inc. Warrant in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
336% more capital invested
Capital invested by funds: $39K → $170K (+$131K)
0% more funds holding
Funds holding: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$83 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$23K |
BNGOW Hedge Fund Activity: Q4 2020 in Review
4 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics, Inc. Warrant (BNGOW) for Q4 2020, worth a combined $170K — up 336% from $39K a quarter earlier.
Fund positioning in BNGOW was balanced in Q4 2020: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $83. The largest seller was Susquehanna International Group, exiting entirely with an estimated $23K sold.
- 4 institutional investors held Bionano Genomics, Inc. Warrant (BNGOW) as of Q4 2020, unchanged from Q3 2020.
- Funds reported $170K of Bionano Genomics, Inc. Warrant stock for Q4 2020, up 336% quarter-over-quarter.
- 1 fund opened new Bionano Genomics, Inc. Warrant positions in Q4 2020 and 1 closed out, a net change of 0 holders.
- The largest Bionano Genomics, Inc. Warrant buyer in Q4 2020 was UBS Group, an estimated $83 added.
- The largest Bionano Genomics, Inc. Warrant seller in Q4 2020 was Susquehanna International Group, an estimated $23K sold.
Based on aggregated 13F filings for Q4 2020.